Regarding the function of SEMA3C in breast cancer, our study showed SEMA3C was down-regulated in primary tumours with further reduced expression in the aggressive subtype Her2 and basal-like tumours, indicating a tumour suppressor role of SEMA3C in breast cancer. This evidence concerns the gene SEMA3C and breast carcinoma.